Isis Pharmaceuticals Reports Positive Phase 1 Data on Isis-ANGPTL3 Rx

Monday, March 23, 2015 1 min read

Key Takeaway: Isis Pharmaceuticals Reports Positive Phase 1 Data on Isis-ANGPTL3 Rx